JULIE GASTIER-FOSTER to Osteosarcoma
This is a "connection" page, showing publications JULIE GASTIER-FOSTER has written about Osteosarcoma.
Connection Strength
0.784
-
Integrated DNA Copy Number and Expression Profiling Identifies IGF1R as a Prognostic Biomarker in Pediatric Osteosarcoma. Int J Mol Sci. 2022 Jul 21; 23(14).
Score: 0.167
-
Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma. JAMA Oncol. 2020 05 01; 6(5):724-734.
Score: 0.143
-
Genome-wide association study identifies the GLDC/IL33 locus associated with survival of osteosarcoma patients. Int J Cancer. 2018 04 15; 142(8):1594-1601.
Score: 0.122
-
A Genome-Wide Scan Identifies Variants in NFIB Associated with Metastasis in Patients with Osteosarcoma. Cancer Discov. 2015 Sep; 5(9):920-31.
Score: 0.102
-
Germline TP53 variants and susceptibility to osteosarcoma. J Natl Cancer Inst. 2015 Jul; 107(7).
Score: 0.101
-
Genome-wide association study identifies two susceptibility loci for osteosarcoma. Nat Genet. 2013 Jul; 45(7):799-803.
Score: 0.089
-
Genomic Profiling of Childhood Tumor Patient-Derived Xenograft Models to Enable Rational Clinical Trial Design. Cell Rep. 2019 11 05; 29(6):1675-1689.e9.
Score: 0.035
-
Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for Thirteen Cancer Types. J Natl Cancer Inst. 2015 Dec; 107(12):djv279.
Score: 0.026